Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Cancer Surgery Trials

Ohio

Cancer surgery and procedure trials in Ohio

130 cancer surgery and procedure studies are recruiting participants at sites in 61 cities across Ohio as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 350-9284
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Ohio city with a recruiting study

By research area: Lymphoma (42), Lung Cancer (31), Breast Cancer (21), Prostate Cancer (16), Pancreatic Cancer (11), Melanoma (9).

Columbus (103), Cleveland (40), Cincinnati (35), Dayton (29), Centerville (22), Franklin (21), Greenville (21), Troy (19), Canton (18), Toledo (17), Sylvania (15), Akron (14), West Chester (13), Westerville (11), Avon (10), Delaware (10), Mansfield (10), Marion (10), Belpre (9), Chillicothe (9), Dublin (9), Newark (9), Springfield (9), Beachwood (8), Marysville (8), Zanesville (8), Kettering (7), Mentor (7), Mount Vernon (7), Perrysburg (7), Portsmouth (7), Pickerington (6), Athens (5), Grove City (5), Lancaster (5), Marietta (5), Mayfield Heights (5), Barberton (3), Beavercreek (3), Boardman (3), Findlay (3), Medina (3), Warren (3), Youngstown (3), Independence (2), Sandusky (2), Steubenville (2), Wooster (2), Alliance (1), Chardon (1), Gahanna (1), Lima (1), Middleburg Heights (1), New Albany (1), Orange (1), Parma (1), Ravenna (1), Strongsville (1), Warrensville Heights (1), Westlake (1), Wilmington (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Ohio

Basic details from each study's public record (the 12 most recently updated of 130). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Columbus
    Registry record
    NCT03606967 · updated
  2. Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Columbus
    Registry record
    NCT05422794 · updated
  3. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    • Phase 2
    • All ages
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Athens · Avon · Beachwood · and 29 more U.S. locations
    Registry record
    NCT05564377 · updated
  4. Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

    • Phase 2
    • Ages 35 and older
    • Female participants
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Columbus
    Registry record
    NCT05941520 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Ohio on ClinicalTrials.gov.

Lung cancer: recently updated in Ohio

  1. Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Cleveland · Columbus
    Registry record
    NCT04665739 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Ohio on ClinicalTrials.gov.

Prostate cancer: recently updated in Ohio

  1. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Belpre · Chillicothe · Columbus · and 13 more U.S. locations
    Registry record
    NCT03866382 · updated
  2. Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Columbus
    Registry record
    NCT05691465 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Ohio on ClinicalTrials.gov.

Melanoma: recently updated in Ohio

  1. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Centerville · Dayton · Franklin · and 2 more U.S. locations
    Registry record
    NCT05136196 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Ohio on ClinicalTrials.gov.

Lymphoma: recently updated in Ohio

  1. Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Cincinnati · Columbus · West Chester
    Registry record
    NCT03739814 · updated
  2. Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Columbus
    Registry record
    NCT04301076 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Ohio on ClinicalTrials.gov.

Pancreatic cancer: recently updated in Ohio

  1. APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Centerville · Dayton · Franklin · and 2 more U.S. locations
    Registry record
    NCT04858334 · updated
  2. Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Columbus
    Registry record
    NCT05372614 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Ohio on ClinicalTrials.gov.

Ask about studies in Ohio

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.

Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 350-9284

or send a short form

How should we reach you?

Call